| Last Price$45.66 | Day Change (%)1.33% |
| Open Price$45.35 | Day Change ($)0.60 |
| Day Range45.35–45.94 | 52-Week Range30.25–47.45 |
As of Mon 06/17/2013 05:00 PM EDT | USD
St . Jude Medical Signs Equity Investment and Option to Purchase Agreement with Spinal Modulation
Welcome to the St . Jude Medical's First Quarter 2013 Earnings Conference Call. Hosting the call today is Dan Starks, Chairman, President, and Chief Executive Officer of St . Jude Medical .
Welcome to St . Jude Medical's Fourth Quarter and Full Year 2012 Earnings Conference Call. Hosting the call today is Dan Starks, Chairman, President and Chief Executive Officer of St . Jude Medical .
Welcome to the St . Jude Medical Second Quarter Earnings Conference Call. Hosting the call today is Dan Starks, Chairman, President and Chief Executive Officer of St . Jude Medical .
Welcome to St . Jude Medical's Third Quarter Earnings Conference Call. Hosting the call today is Dan Starks, Chairman, President and Chief Executive Officer of St . Jude Medical .
Welcome to St . Jude Medical's Second Quarter Earnings Conference Call. Hosting the call today is Dan Starks, Chairman, President and Chief Executive Officer of St . Jude Medical .
Welcome to St . Jude Medical's Third Quarter Earnings Conference Call. Hosting the call today is Dan Starks, Chairman, President and Chief Executive Officer of St . Jude Medical .
Welcome to the St . Jude Medical's First Quarter Earnings Conference Call. Hosting the call today is Dan Starks, Chairman, President, and Chief Executive Officer of St . Jude Medical .
Welcome to St . Jude Medical's Fourth Quarter and Full Year 2011 Earnings Conference Call. Hosting the call today is Dan Starks, Chairman, President and Chief Executive Officer of St . Jude Medical .
One Year Data from St . Jude Medical Study Demonstrates Safe, Rapid and Sustained Blood Pressure Reduction with EnligHTN Renal Denervation Technology